Infant with status epilepticus secondary to systemic lidocaine toxicity from topical application

BMJ Case Rep. 2020 Jan 12;13(1):e233119. doi: 10.1136/bcr-2019-233119.

Abstract

A previously healthy 11-month-old infant presented to the emergency department in status epilepticus. There was no clear trigger of her seizure activity which resolved with benzodiazepines and fosphenytoin. On further review, her parents disclosed that she had been prescribed topical 4% lidocaine cream for a groin rash and was ultimately diagnosed with lidocaine toxicity in the emergency department. She was monitored in the intensive care unit without cardiovascular abnormalities or recurrence of seizure activity. Emergency medicine providers must maintain a broader differential of status epileptics and be able to recognise and manage potential complications from systemic lidocaine toxicity.

Keywords: epilepsy and seizures; neurology (drugs and medicines); paediatrics (drugs and medicines); poisoning.

Publication types

  • Case Reports

MeSH terms

  • Administration, Topical*
  • Anticonvulsants / therapeutic use
  • Diagnosis, Differential
  • Female
  • Humans
  • Infant
  • Lidocaine / toxicity*
  • Lorazepam / therapeutic use
  • Phenytoin / analogs & derivatives
  • Phenytoin / therapeutic use
  • Status Epilepticus / chemically induced*
  • Status Epilepticus / drug therapy

Substances

  • Anticonvulsants
  • Phenytoin
  • Lidocaine
  • fosphenytoin
  • Lorazepam